Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/IRCT20170705034908N3
IRCT20170705034908N3RecruitingPhase 2

Comparison of the Effectiveness of Ferric carboxymaltose versus Iron sucrose in Anemia correction /impact on Transfusion Requirements in patients undergoing cardiac surgery

Tabriz University of Medical Sciences0 sites66 target enrollmentStarted: TBDLast updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Phase 2
Status
Recruiting
Enrollment
66
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to no limit (—)
Sex
All

Inclusion Criteria

  • •People over the age of 18 who are undergoing cardiac surgery for the first time.
  • •Men with Hb<13 and women with Hb<12 and (ferritin 100-299 ng / ml and transferransfine saturation < 20%)
  • •People who have discontinued the Warfarin at least 72 hours before surgery.
  • •People who have discontinued the anti-platelet at least drugs 3-5 days bofore sugery.

Exclusion Criteria

  • •Elimination of patients with liver disorders
  • •Elimination of patients with inherited and well-known coagulation disorders
  • •Elimination Emergency sugeries
  • •Elimination pregnant women
  • •Redo surgery

Investigators

Similar Trials

Completed
Phase 2
Effect of intravenous iron in the treatment of chronic iron deficiency anemia in colon cancer patientsIron deficiency anaemia.Iron deficiency anaemia
IRCT2015092111560N9Vice Chancellor for research, Iran University of Medical Sciences70
Terminated
Phase 2
Iron Infusion in Heart Failure StudyIron DeficiencyCardiovascular - Diseases of the vasculature and circulation including the lymphatic systemChronic Heart Failure
ACTRN12615000952549Professor Andrew Sindone82
Completed
Not Applicable
To compare two types of injectable iron therapies ( Ferric carboxymaltose and iron sucrose) for treatment of anemia (low Hemoglobin) due to heavy menstrual bleeding
CTRI/2015/09/006224Dr Alka Kriplani60
Recruiting
Phase 3
A clinical trial to study efficacy of a injectable iron preparation (FCM) as compared to oral iron in the treatment of iron deficiency anemia in 3rd trimester of pregnancy.
CTRI/2017/06/008884Armed Forces Medical College173
Active, not recruiting
Phase 1
Iron Deficiency in cardiac surgeryIron deficiency in cardiac surgeryMedDRA version: 20.0Level: LLTClassification code 10067709Term: HypoferrismSystem Organ Class: 100000004861
EUCTR2017-001823-26-ITIVERSITÀ CAMPUS BIO-MEDICO DI ROMA50